0002008372-24-000001.txt : 20240117 0002008372-24-000001.hdr.sgml : 20240117 20240116191041 ACCESSION NUMBER: 0002008372-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240117 DATE AS OF CHANGE: 20240116 EFFECTIVENESS DATE: 20240117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rapalogix Health, Inc. CENTRAL INDEX KEY: 0002008372 ORGANIZATION NAME: IRS NUMBER: 933155788 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-502595 FILM NUMBER: 24536445 BUSINESS ADDRESS: STREET 1: 228 PARK AVE S, SUITE 66643 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: (650)856-3700 MAIL ADDRESS: STREET 1: 228 PARK AVE S, SUITE 66643 CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0002008372 Rapalogix Health, Inc. 228 PARK AVE S, SUITE 66643 NEW YORK NY NEW YORK 10003 (650)856-3700 DELAWARE None None Corporation true 2023 Rahul Mehta 228 Park Ave S suite 66643 New York NY NEW YORK 10003 Executive Officer James Peyer 228 Park Ave S suite 66643 New York NY NEW YORK 10003 Director Juliette Han 228 Park Ave S Suite 66643 New York NY NEW YORK 10003 Executive Officer Director Joan Mannick 228 Park Ave S suite 66643 New York NY NEW YORK 10003 Director Brent Saunders 228 Park Ave S suite 66643 New York NY NEW YORK 10003 Executive Officer Director Doris Day 228 Park Ave S suite 66643 New York NY NEW YORK 10003 Director Biotechnology Decline to Disclose 06b false 2023-12-22 false true false 0 8000000 8000000 0 Sale of shares of Series Seed Preferred Stock. true 14 0 0 0 0 false Rapalogix Health, Inc. /s/ Rahul Mehta Rahul Mehta Chief Executive Officer 2024-01-11